1 se fluticasone propionate were found to have adrenal suppression.

2 c dexamethasone (p </= .05), consistent with adrenal suppression.

3 linically significant hypothalamic-pituitary-adrenal suppression and cutaneous atrophy in children.

4 st specifically related to the potential for adrenal suppression and growth retardation.

5 y be administered therapeutically to prevent adrenal suppression and worse outcomes.

6   Seven studies addressed the development of adrenal suppression associated with the administration o

7 acological doses of corticoids may result in adrenal suppression but with individual sensitivity.

8  age: 8-21, USA) and the Pharmacogenetics of adrenal suppression cohort (n = 391, age: 5-18, UK) to t

9 about adverse effects, especially growth and adrenal suppression, induced by systemic CS in children.

10                                              Adrenal suppression may occur in at least one fifth of t

11 pionate are used, growth may be retarded and adrenal suppression may occur.

12 mprovement in symptoms of CFS, the degree of adrenal suppression precludes its practical use for CFS.

13 es < 20 nmol/l are undetectable and indicate adrenal suppression, values > 69 nmol/l are considered t

14 ticoids should be subjected to screening for adrenal suppression when anticipated discontinuation of

15 vironment Study, and the Pharmacogenetics of Adrenal Suppression with Inhaled Steroid Study).